This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3pp3
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 3pp3 is ON HOLD Authors: Hopfner, K.-P., Lammens, A. Description: Epitope characterization and crystal structure of GA101 provide insights into the...) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3pp3 is ON HOLD | + | The entry 3pp3 is ON HOLD until Paper Publication |
Authors: Hopfner, K.-P., Lammens, A. | Authors: Hopfner, K.-P., Lammens, A. | ||
| Line 7: | Line 7: | ||
Description: Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti-CD20 antibodies | Description: Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti-CD20 antibodies | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 15 08:24:37 2010'' |
Revision as of 05:12, 15 December 2010
Unreleased structure
The entry 3pp3 is ON HOLD until Paper Publication
Authors: Hopfner, K.-P., Lammens, A.
Description: Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti-CD20 antibodies
Page seeded by OCA on Wed Dec 15 08:24:37 2010
